Overview

Testosterone Undecanoate and Quality of Life of Men and Spouses

Status:
Unknown status
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
This study will be conducted as a prospective, single-center (multiple clinics), single-arm open phase IV study. the study will follow hypogonadal patients, and aimed to confirm the hypothesis that testosterone undecanoate improves the patient satisfaction and quality of life, with parallel improvement in their spouses's quality of life and satisfaction. Each patient/spouse will serve as his own control.
Details
Lead Sponsor:
Meir Medical Center
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate